I
Impax
Impax agreed to pay $15 million to resolve claims it conspired to suppress generic Opana ER alternatives, causing overpayment by third party payers.
ClosedSelected statesClaim status: Closed on January 5, 2023Payout: VariesNo longer claimable
About this settlement
Alleged price-fixing conspiracy involving brand and generic Opana ER pain medication.
This settlement resolves claims that Impax conspired to suppress generic alternatives to Opana ER, leading to inflated prices paid by purchasers and third party payers across multiple states.
Who qualifies
- Individuals or entities who purchased, paid for, or reimbursed brand or generic Opana ER.
- Purchases made between April 2011 and September 2018.
- Purchases made in specified states including Arizona, California, Florida, and others.
Varies
Claim status: Closed on January 5, 2023